Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Timeline

Inmazeb

Regeneron's triple Ebola monoclonal antibody cocktail; FDA-approved 2020 for Zaire only; not effective against Bundibugyo.

2 of 2 entries (2 events, 0 interactions)

Filters
#317 May

Mentioned in: USAID outbreak unit gone by PHEIC

Pandemics and Biosecurity
#317 May

FDA-approved Zaire ebolavirus monoclonal antibody with no Bundibugyo efficacy

Pandemics and Biosecurity: No vaccine, no treatment, no MCM
← Back to Inmazeb